Canaccord Genuity Downgrades GreenLight Biosciences (GRNA) to Hold

May 31, 2023 7:08 AM EDT
Get Alerts GRNA Hot Sheet
Price: $0.30 --0%

Rating Summary:
    0 Buy, 2 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Canaccord Genuity analyst Bobby Burleson downgraded GreenLight Biosciences (NASDAQ: GRNA) from Buy to Hold with a price target of $0.30 (from $4.00).


For an analyst ratings summary and ratings history on GreenLight Biosciences click here. For more ratings news on GreenLight Biosciences click here.


Shares of GreenLight Biosciences closed at $0.29 yesterday.


You May Also Be Interested In





Related Categories

Analyst PT Change, Downgrades